NEULAND LABORATORIES
|
The Current P/S Ratio of NEULAND LABORATORIES is 14.46.
Share Price | ₹15,022.5 | Sep 24,2025 |
Market Cap | ₹19,228.8 Cr | |
Sales-TTM | ₹1,330.0 Cr | TTM-Consolidated Results |
Price/Sales | 14.46x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of NEULAND LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹19,228.8 Cr] as on Sep 24,2025
(/) Sales [ ₹1,330.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 14.46x ]
Thus, for NEULAND LABORATORIES , the investors are currently willing to pay '14.46 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of NEULAND LABORATORIES !
The chart below summarizes the trend in P/S Ratio of NEULAND LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of NEULAND LABORATORIES
PS Ratio Performance Analysis for NEULAND LABORATORIES
- NEULAND LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 4.37x.
- NEULAND LABORATORIES 's operated at median p/e ratio of 2.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NEULAND LABORATORIES 's p/e ratio peaked in Mar2025 at 10.49x.
- NEULAND LABORATORIES 's p/e ratio hit its five-year low in Mar2022 of 1.38x.
How does NEULAND LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
NEULAND LABORATORIES | 1,330.0 | 14.46 | 19,228.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.26 | 390,348.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 16.46 | 158,840.0 |
CIPLA LTD | 27,811.2 | 4.47 | 124,222.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.34 | 122,346.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.24 | 108,437.0 |
MANKIND PHARMA LTD | 12,956.2 | 8.06 | 104,401.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.41 | 104,165.0 |
LUPIN LTD | 23,375.9 | 3.89 | 90,949.6 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.98 | 63,394.5 |
ABBOTT INDIA LTD | 6,589.9 | 9.72 | 64,073.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NEULAND LABORATORIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.98x |
Max industry PS | 16.46x |
Median industry PS | 7.26x |
Average industry PS | 7.66x |
You may also like the below Video Courses